Award

PHE_Scientific_Provision of T Cell Testing (National Immunisation Programme)

PUBLIC HEALTH ENGLAND

This public procurement record has 1 release in its history.

Award

05 Oct 2021 at 12:00

Award Notice
Summary of the contracting process

The procurement process led by Public Health England (PHE) involved the awarding of a contract for the provision of T Cell Testing services as part of the National Immunisation Programme. This initiative, titled "PHE_Scientific_Provision of T Cell Testing," falls under the laboratory services industry category and is located in London, United Kingdom. The award was published on 5th October 2021, with the contract starting on 1st September 2021 and concluding on 31st January 2023, which may be extended for up to an additional year. The procurement method used was selective, employing a call-off from a framework agreement to secure Oxford Immunotec as the sole supplier for testing related to SARS-CoV-2.

This tender represents significant opportunities for businesses involved in laboratory services and those specialising in immunological testing, particularly in the context of COVID-19 response efforts. Companies well-suited to compete for similar future tenders include small and medium-sized enterprises (SMEs) with expertise in immunology or diagnostic services who can offer innovative approaches to T cell testing. Engaging in such contracts not only opens pathways to new business relationships with public sector clients but also contributes to vital public health initiatives.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

PHE_Scientific_Provision of T Cell Testing (National Immunisation Programme)

Notice Description

Public Health England (PHE) has awarded a contract to Oxford Immunotec under Lot 2 of the National Microbiology Framework for services to carry T-SPOT(r) Discovery SARS-CoV-2 assay tests as part of the National Immunisation Programme, a study which PHE has been tasked to perform to evaluate the immune response following COVID-19 vaccines. The provision of T-SPOT Discovery SARS-CoV-2 testing will be used to identify the presence or absence of T cells that are reactive to SARS-CoV-2 peptides. This insight is useful for a number of applications related to understanding an individual's T cell response to SARS-CoV-2 infection. The test uses a modified ELISPOT approach (T-SPOT(r) Technology) to the Interferon-gamma releasing assay (IGRA). The award to Oxford Immunotec will enable PHE to adhere to the decision made by the UK Vaccines Taskforce who selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. The Vaccines Taskforce has emphasised that it is important to be able to assess the different vaccines head-to-head and employing Oxford Immunotec's T-SPOT technology will measure the magnitude of the SARS-CoV-2 protein-specific T cell response of different vaccine candidates for cross-comparisons. This will ensure that the evaluation of the National Immunisation Programme being carried out by PHE is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies. The Contract will commence on 01 September 2021 and the initial period will end on 31 January 2023. The Term may be extended by a further period of up to 12 months if required.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-2244ca51-3cd7-4aff-b06f-754bbbd95483
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/0cd29d33-cdbf-46ec-b862-701efea91a60
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Services
Procurement Method
Selective
Procurement Method Details
Call-off from a framework agreement
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

71 - Architectural, construction, engineering and inspection services

CPV Codes

71900000 - Laboratory services

Notice Value(s)

Tender Value
£350,000 £100K-£500K
Lots Value
Not specified
Awards Value
£350,000 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
5 Oct 20214 years ago
Submission Deadline
23 Aug 2021Expired
Future Notice Date
Not specified
Award Date
29 Sep 20214 years ago
Contract Period
31 Aug 2021 - 31 Jan 2023 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
PUBLIC HEALTH ENGLAND
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
NW9 5EQ
Post Town
North West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI7 Outer London - West and North West
Small Region (ITL 3)
TLI71 Barnet
Delivery Location
Not specified
Local Authority
Barnet
Electoral Ward
Colindale South
Westminster Constituency
Hendon

Supplier Information

Number of Suppliers
1
Supplier Name

OXFORD IMMUNOTEC

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-2244ca51-3cd7-4aff-b06f-754bbbd95483-2021-10-05T13:00:02+01:00",
    "date": "2021-10-05T13:00:02+01:00",
    "ocid": "ocds-b5fd17-2244ca51-3cd7-4aff-b06f-754bbbd95483",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "CF-0392400D0O000000rwimUAA1",
        "title": "PHE_Scientific_Provision of T Cell Testing (National Immunisation Programme)",
        "description": "Public Health England (PHE) has awarded a contract to Oxford Immunotec under Lot 2 of the National Microbiology Framework for services to carry T-SPOT(r) Discovery SARS-CoV-2 assay tests as part of the National Immunisation Programme, a study which PHE has been tasked to perform to evaluate the immune response following COVID-19 vaccines. The provision of T-SPOT Discovery SARS-CoV-2 testing will be used to identify the presence or absence of T cells that are reactive to SARS-CoV-2 peptides. This insight is useful for a number of applications related to understanding an individual's T cell response to SARS-CoV-2 infection. The test uses a modified ELISPOT approach (T-SPOT(r) Technology) to the Interferon-gamma releasing assay (IGRA). The award to Oxford Immunotec will enable PHE to adhere to the decision made by the UK Vaccines Taskforce who selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. The Vaccines Taskforce has emphasised that it is important to be able to assess the different vaccines head-to-head and employing Oxford Immunotec's T-SPOT technology will measure the magnitude of the SARS-CoV-2 protein-specific T cell response of different vaccine candidates for cross-comparisons. This will ensure that the evaluation of the National Immunisation Programme being carried out by PHE is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies. The Contract will commence on 01 September 2021 and the initial period will end on 31 January 2023. The Term may be extended by a further period of up to 12 months if required.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "71900000",
            "description": "Laboratory services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "NW9 5EQ"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 350000,
            "currency": "GBP"
        },
        "procurementMethod": "selective",
        "procurementMethodDetails": "Call-off from a framework agreement",
        "tenderPeriod": {
            "endDate": "2021-08-23T17:00:00+01:00"
        },
        "contractPeriod": {
            "startDate": "2021-09-01T00:00:00+01:00",
            "endDate": "2023-01-31T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "services"
    },
    "parties": [
        {
            "id": "GB-CFS-179079",
            "name": "Public Health England",
            "identifier": {
                "legalName": "Public Health England"
            },
            "address": {
                "streetAddress": "61 Colindale Avenue,",
                "locality": "London",
                "postalCode": "NW9 5EQ",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Tee Agbo",
                "email": "tee.agbo@phe.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-185253",
            "name": "Oxford Immunotec",
            "identifier": {
                "legalName": "Oxford Immunotec"
            },
            "address": {
                "streetAddress": "94C Innovation Drive, Milton Park,, Abingdon, Oxon,, OX14 4RZ"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-179079",
        "name": "Public Health England"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-2244ca51-3cd7-4aff-b06f-754bbbd95483-1",
            "status": "active",
            "date": "2021-09-30T00:00:00+01:00",
            "datePublished": "2021-10-05T13:00:02+01:00",
            "value": {
                "amount": 350000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-185253",
                    "name": "Oxford Immunotec"
                }
            ],
            "contractPeriod": {
                "startDate": "2021-09-01T00:00:00+01:00",
                "endDate": "2023-01-31T23:59:59Z"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/0cd29d33-cdbf-46ec-b862-701efea91a60",
                    "datePublished": "2021-10-05T13:00:02+01:00",
                    "format": "text/html",
                    "language": "en"
                },
                {
                    "id": "2",
                    "description": "Order Form - Provision for T-SPOT Discovery SARS-CoV-2 testing [fully executed]_Redacted",
                    "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Nbjf/jw400nXTeO66B8a.uuxY3eKAExeOZxl5MdOcxeaEHX8"
                }
            ]
        }
    ]
}